Skip to content
10-Q

Quarterly Report

ACCUSTEM SCIENCES, INC. ACUT

0001493152-24-020584

← back to feed
Filed
May 20, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 10, 2024 11.35M sh
Current Liabilities Q1 2024 · Mar 31, 2024 $2.67M
Current Liabilities Q1 2024 · Dec 31, 2023 $2.25M
Total Liabilities Q1 2024 · Mar 31, 2024 $2.67M
Total Liabilities Q1 2024 · Dec 31, 2023 $2.25M
Current Assets Q1 2024 · Mar 31, 2024 $47.8K
Current Assets Q1 2024 · Dec 31, 2023 $129.85K
Total Assets Q1 2024 · Mar 31, 2024 $50.94K
Total Assets Q1 2024 · Dec 31, 2023 $133.9K
Shares Diluted Q1 2024 · Mar 31, 2023 11.35M sh
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$446.09K
Stockholders Equity Q1 2024 · Mar 31, 2023 −$946.68K
Stockholders Equity Q1 2024 · Dec 31, 2022 −$139.55K
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.07
Eps Basic Q1 2024 · Mar 31, 2023 −$0.07
Sga Expense Q1 2024 · Mar 31, 2023 $817.74K
Rd Expense Q1 2024 · Mar 31, 2023 $15.6K
Net Income Q1 2024 · Mar 31, 2023 −$833.34K
Operating Income Q1 2024 · Mar 31, 2023 −$833.34K